search
Back to results

Refeeding in Post-ERCP Pancreatitis

Primary Purpose

Post-ERCP Pancreatitis

Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
early refeeding
delayed refeeding
Sponsored by
Yonsei University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Post-ERCP Pancreatitis

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients aged 20 to 80
  2. As patients who developed pancreatitis after receiving ERCP, the following must be satisfied at the same time.

    1. increased serum amylase or lipase 3 times higher than the normal range, at 4 hours after ERCP or the morning of the following day,
    2. New or worsening abdominal pain compatible with pancreatitis, arising 4 hours after ERCP or the next morning

Exclusion Criteria:

  1. If the intended procedure is not completed
  2. If complications such as abdominal perforation or bleeding have occurred or are suspected
  3. If it is judged as severe acute pancreatitis with multi-organ failure la.
  4. When PEP has occurred, but additional imaging tests and endoscopy for diagnosis of the underlying disease or treatment of complications of the patient are required, and fasting is necessary regardless of this study
  5. Patients with a history of chronic pancreatitis
  6. Pregnant women, lactating women

Sites / Locations

  • Korea University Ansan HospitalRecruiting
  • Pusan National University HospitalRecruiting
  • Gyeongsang National University Changwon HospitalRecruiting
  • Kyungpook National University School of MedicineRecruiting
  • Gachon University College of MedicineRecruiting
  • Yonsei University College of MedicineRecruiting
  • Seoul Metropolitan Government Boramae Medical CenterRecruiting
  • Seoul National University HospitalRecruiting
  • Seoul St. Mary's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

early refeeding group

delayed refeeding group

Arm Description

In the early refeeding group, oral diet is started 24 hours after PEP is confirmed.

In the delayed refeeding group, oral diet is started after confirmation of restoring of normal bowel sound, pain decreasing below VAS 2.

Outcomes

Primary Outcome Measures

hospitalization period for PEP
If the patient is tolerable for more than 24 hours after the soft diet (abdominal pain improvement, lab amylase/lipase level decreases to less than 2 times the upper normal limit, it is judged that PEP has improved and the discharge criteria have been satisfied. From the point of diagnosis of PEP to the point of time when the discharge criteria are satisfied is defined as the "hospitalization period for PEP".

Secondary Outcome Measures

Incidence of acute severe pancreatitis
comparing rate of incidence of severe acute pancreatitis
readmission rate (<30 days)
comparing readmission rate of each group until 30 days after discharge
mortality rate
comparing mortality rat of each group during hospitalization
complication rate
comparing complication rate including nausea/vomiting, recurrent abdominal pain, necrotizing pancreatitis of each group during hospitalization

Full Information

First Posted
February 7, 2021
Last Updated
October 24, 2022
Sponsor
Yonsei University
search

1. Study Identification

Unique Protocol Identification Number
NCT04750044
Brief Title
Refeeding in Post-ERCP Pancreatitis
Official Title
Timing of Oral Refeeding in Post-ERCP Pancreatitis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 18, 2021 (Actual)
Primary Completion Date
November 10, 2022 (Anticipated)
Study Completion Date
December 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Endoscopic retrograde cholangio-pancreatography (ERCP) is the most commonly used technique for diagnosis and treatment in the treatment of bile duct diseases including bile duct cholelithiasis and malignant/benign biliary obstruction. In particular, ERCP is an essential procedure for the removal of bile duct gallstones and bile drainage in malignant/benign biliary obstruction patients. Among ERCP-related complications, especially "post-ERCP pancreatitis (PEP)", which occurs due to the anatomical structure of the pancreatic biliary system, statistically occurs in about 5-10% of patients who first received ERCP. It is known, and treatment for PEP is the same as treatment for general acute pancreatitis but is known to have a relatively worse prognosis. The basis of treatment for acute pancreatitis is a conservative treatment based on fasting and fluid treatment, and starting oral diet after abdominal pain and pancreatic enzyme levels (amylase/lipase) normalized. However, a recent study reported that early oral diet could improve the patient's prognosis. According to a systematic review of 11 randomized trial papers by Valerie et al., it was reported that the early diet had the effect of reducing hospital stay without increasing adverse events when comparing the prognosis of the early refeeding group and delayed refeeding group. This result is theoretically considered to be because the oral diet has the advantage of increasing intestinal permeability, gut motility and reducing the likelihood of pancreatic necrosis/ infection compared to the parenteral diet. As above, PEP has the same treatment method as general acute pancreatitis but is known to have a relatively worse prognosis. However, the effect of an early diet recently attempted in acute pancreatitis has not been reported in patients with PEP. Therefore, we investigate the effects of early and delayed diets on the prognosis of patients with PEP through a prospective multicenter study.
Detailed Description
Selection of research subjects A total of 80 patients, who have occurred pancreatitis after ERCP, will be enrolled at Yonsei University Sinchon Severance Hospital, Seoul National University Hospital, Dongguk University Ilsan Hospital, Gachon University Gil Hospital, Gyeongsang National University Changwon Hospital, Kyungpook National University Hospital, Seoul St. Mary's Hospital, Korea University Ansan Hospital, Pusan National University Hospital. The purpose and contents of this clinical trial are informed in detail to the subject and consent is obtained. Evaluation of eligibility Eligibility is determined based on the basic patient data including physical examination, vital signs, body measurements, medical history, concomitant drugs, laboratory tests, and other basic examinations made at the first visit. Grouping and randomization After ERCP was performed, the study subjects who were judged to have PEP according to enroll criteria were divided into early and delayed refeeding groups using a random number table and assigned 1:1 to proceed with the study. Timing of refeeding In the early refeeding group, oral diet is started 24 hours after PEP is confirmed. In the delayed refeeding group, oral diet is started after confirmation of restoring of normal bowel sound, pain decreasing below VAS 2. The oral diet starts with SOW (Sips of water) and builds up sequentially in the order of clear liquid diet-soft diet, considering patient tolerability. Interruption of refeeding In both early and delayed refeeding groups, the oral diet is stopped when the pain scale the patient complains after starting oral diet increases to VAS 5 points or more, or the patient refuses to eat due to abdominal pain or other reasons. The diet is restarted after the amylase/lipase level decreases below the upper normal limit, the patient's pain has disappeared, and the bowel movement is restored. Dropout criteria In the case of delayed diet group when symptoms persist for more than 96 hours and cannot start a diet When fasting is necessary for other reason, such as an imaging test or endoscopy When it is determined that a parenteral diet is necessary for reasons such as difficulty swallowing When the researcher judged that the clinical trial cannot be continued Discharge criteria and hospitalization period for PEP If the patient is tolerable for more than 24 hours after the soft diet (abdominal pain improvement, lab amylase/lipase level decreases to less than 2 times the upper normal limit, it is judged that PEP has improved and the discharge criteria have been satisfied. From the point of diagnosis of PEP to the point of time when the discharge criteria are satisfied is defined as the "hospitalization period for PEP".

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-ERCP Pancreatitis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
early refeeding group
Arm Type
Experimental
Arm Description
In the early refeeding group, oral diet is started 24 hours after PEP is confirmed.
Arm Title
delayed refeeding group
Arm Type
Active Comparator
Arm Description
In the delayed refeeding group, oral diet is started after confirmation of restoring of normal bowel sound, pain decreasing below VAS 2.
Intervention Type
Other
Intervention Name(s)
early refeeding
Intervention Description
In the early refeeding group, oral diet is started 24 hours after PEP is confirmed. The oral diet starts with SOW (Sips of water) and builds up sequentially in the order of clear liquid diet-soft diet, considering patient tolerability.
Intervention Type
Other
Intervention Name(s)
delayed refeeding
Intervention Description
In the delayed refeeding group, oral diet is started after confirmation of restoring of normal bowel sound, pain decreasing below VAS 2. The oral diet starts with SOW (Sips of water) and builds up sequentially in the order of clear liquid diet-soft diet, considering patient tolerability.
Primary Outcome Measure Information:
Title
hospitalization period for PEP
Description
If the patient is tolerable for more than 24 hours after the soft diet (abdominal pain improvement, lab amylase/lipase level decreases to less than 2 times the upper normal limit, it is judged that PEP has improved and the discharge criteria have been satisfied. From the point of diagnosis of PEP to the point of time when the discharge criteria are satisfied is defined as the "hospitalization period for PEP".
Time Frame
up to 1 month
Secondary Outcome Measure Information:
Title
Incidence of acute severe pancreatitis
Description
comparing rate of incidence of severe acute pancreatitis
Time Frame
up to 1 month
Title
readmission rate (<30 days)
Description
comparing readmission rate of each group until 30 days after discharge
Time Frame
up to 1 month
Title
mortality rate
Description
comparing mortality rat of each group during hospitalization
Time Frame
up to 1 month
Title
complication rate
Description
comparing complication rate including nausea/vomiting, recurrent abdominal pain, necrotizing pancreatitis of each group during hospitalization
Time Frame
up to 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 20 to 80 As patients who developed pancreatitis after receiving ERCP, the following must be satisfied at the same time. increased serum amylase or lipase 3 times higher than the normal range, at 4 hours after ERCP or the morning of the following day, New or worsening abdominal pain compatible with pancreatitis, arising 4 hours after ERCP or the next morning Exclusion Criteria: If the intended procedure is not completed If complications such as abdominal perforation or bleeding have occurred or are suspected If it is judged as severe acute pancreatitis with multi-organ failure la. When PEP has occurred, but additional imaging tests and endoscopy for diagnosis of the underlying disease or treatment of complications of the patient are required, and fasting is necessary regardless of this study Patients with a history of chronic pancreatitis Pregnant women, lactating women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jung Hyun Jo
Phone
+82-2-2228-2274
Email
junghyunjo83@yuhs.ac
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jung Hyun Jo
Organizational Affiliation
Severance Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Korea University Ansan Hospital
City
Ansan-si
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jung Wan Choe
Facility Name
Pusan National University Hospital
City
Busan
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sung Yong Han
Facility Name
Gyeongsang National University Changwon Hospital
City
Changwon
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jae Min Lee
Facility Name
Kyungpook National University School of Medicine
City
Daegu
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dong Kee Jang
Facility Name
Gachon University College of Medicine
City
Incheon
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eui Joo Kim
Facility Name
Yonsei University College of Medicine
City
Seoul
ZIP/Postal Code
03722
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
JUNGHYUN JO
Phone
+82-2-2228-2274
Email
junghyunjo83@yuhs.ac
Facility Name
Seoul Metropolitan Government Boramae Medical Center
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dong Kee Jang
Facility Name
Seoul National University Hospital
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sang Hyub Lee
Facility Name
Seoul St. Mary's Hospital
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Young Hoon Choi

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Refeeding in Post-ERCP Pancreatitis

We'll reach out to this number within 24 hrs